[Federal Register Volume 73, Number 155 (Monday, August 11, 2008)]
[Notices]
[Pages 46606-46607]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-18599]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary


Defense Health Board Meeting

AGENCY: Department of Defense (DoD).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: Pursuant to the Federal Advisory Committee Act of 1972 (5 
U.S.C., Appendix as amended), the Sunshine in the Government Act of 
1976 (5 U.S.C. 552b, as amended), and 41 CFR 102-3.150, and in 
accordance with section 10(a)(2) of Public Law, the following meeting 
of the Defense Health Board (DHB) is announced:

DATES: September 4, 2008 (8 a.m.-4:15 p.m.) (Open Session). September 
5, 2008 (8:30 a.m.-3:30 p.m.) (Open Session).

ADDRESSES: Sheraton Crystal City, 1800 Jefferson Davis Highway, 
Arlington, VA 22202.

FOR FURTHER INFORMATION CONTACT: Colonel Roger L. Gibson, Executive 
Secretary, Defense Health Board, Five Skyline Place, 5111 Leesburg 
Pike, Suite 810, Falls Church, Virginia 22041-3206, (703) 681-8448, 
EXT. 1228, Fax: (703) 681-3317, <a href="/cdn-cgi/l/email-protection#56243931332478313f34253938163e3778392532783b3f3a"><span class="__cf_email__" data-cfemail="35475a5250471b525c57465a5b755d541b5a46511b585c59">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: Additional information, agenda updates, and 
meeting registration are available online at the Defense Health Board 
Web site, http://www.ha.osd.mil/dhb. The public is encouraged to 
register for the meeting. If special accommodations are required to 
attend (sign language, wheelchair accessibility) please contact Ms. 
Lisa Jarrett at (703) 681-8448 ext. 1280 by August 21, 2008. Written 
statements may be mailed to the above address, e-mailed to 
<a href="/cdn-cgi/l/email-protection#197d717b59717837766a7d37747075"><span class="__cf_email__" data-cfemail="dcb8b4be9cb4bdf2b3afb8f2b1b5b0">[email protected]</span></a> or faxed to (703) 681-3317.
    Purpose of the Meeting: The purpose of the meeting is to address 
and deliberate pending and new Board issues and provide briefings for 
Board members on topics related to ongoing Board business.
    Agenda: On September 4, 2008 during the morning session, the Board 
will receive updates on the activities from Defense Health Board 
subcommittees: Trauma and Injury/Combat Casualty Care, Traumatic Brain 
Injury External Advisory, and the Traumatic Brain Injury Family Care 
Giver's Panel. The Board will discuss plans for identifying best 
practices in health care delivery in response to the recommendations 
outlined in the Board's Task Force for the Future of Military 
Healthcare report. The Board will also receive presentations on the 
basics of the TRICARE Health Plan and address issues of Environmental 
Risk Assessments in Operational Settings. The Vaccine Safety and 
Effectiveness Workgroup and the Biowarfare Countermeasures Subcommittee 
will provide updates on their activities. The Board will conduct an 
administrative session on the afternoon of September 4, 2008.
    On September 5, 2008, the Board will discuss Amputee Care 
Sustainment, the DoD's plan for a Joint Pathology Center, and the 
activities of the Deployment Health Research Center. Questions will be 
presented to the Board on Lyme Disease Therapy and Applied Behavior 
Analysis (ABA) treatment for Autism. The meeting will conclude with 
open discussion and an awards ceremony.
    Pursuant to 5 U.S.C. 552b, as amended, and 41 CFR 102-3.140 through 
102-3.165 and subject availability of space, the Defense Health Board 
meeting from 80 a.m. to 4:15 p.m. on September 4, 2008 and from 8:30 
a.m. to 3:30 p.m. on September 5, 2008 is open to the public. Any 
member of the public wishing to provide input to the Defense Health 
Board should submit a written statement in accordance with 41 CFR 102-
3.140(C) and section 10(a)(3) of the Federal Advisory Committee Act, 
and the procedures described in this notice. Written statement should 
be not longer than two

[[Page 46607]]

type-written pages and must address the following detail: The issue, 
discussion, and a recommended course of action. Supporting 
documentation may also be included as needed to establish the 
appropriate historical context and to provide any necessary background 
information.
    Individuals desiring to submit a written statement may do so 
through the Board's Designated Federal Officer at the address detailed 
above at any point. However, if the written statement is not received 
at least 10 calendar days prior to the meeting, which is subject to 
this notice, then it may not be provided to or considered by the 
Defense Health Board until the next open meeting.
    The Designated Federal Officer will review all timely submissions 
with the Defense Health Board Chairperson, and ensure they are provided 
to members of the Defense Health Board before the meeting that is 
subject to this notice. After reviewing the written comments, the 
Chairperson and the Designated Federal Officer may choose to invite the 
submitter of the comments to orally present their issue during an open 
portion of this meeting or at a future meeting.
    The Designated Federal Officer, in consultation with the Defense 
Health Board Chairperson, may, if desired, allot a specific amount of 
time for members of the public to present their issues for review and 
discussion by the Defense Health Board.

    Dated: August 5, 2008.
Patricia L. Toppings,
OSD Federal Register Liaison Officer, Department of Defense.
 [FR Doc. E8-18599 Filed 8-7-08; 4:15 pm]
BILLING CODE 5001-06-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>